Evidence map›Paper›PMID 38900222›Full record

ArticleFamilial cancer2024

Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case report.

L van Riel, C M Kets, L P van Hest, F H Menko, B G Boerrigter, S M Franken, R M F Wolthuis, H J Dubbink, P J Zondervan, R J A van Moorselaar and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Familial cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

L van RielDepartment of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. l.vanriel@amsterdamumc.nl.
C M KetsDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
L P van HestDepartment of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
F H MenkoDepartment of Clinical Genetics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
B G BoerrigterDepartment of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
S M FrankenDepartment of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
R M F WolthuisDepartment of Human Genetics, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
H J DubbinkDepartment of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
P J ZondervanDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
R J A van MoorselaarDepartment of Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
A C HouwelingDepartment of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
I van de BeekDepartment of Clinical Genetics, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Funding

Myrovlitis Trust MT21_6
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BHDBirt-Hogg-Dubé syndromeFLCNGeneticsMetastasisRenal cell carcinoma

Identifiers

PMID38900222
PMCPMC11512896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.